OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Crystallization of Monosodium Urate
Miguel Martillo, Lama Nazzal, Daria B. Crittenden
Current Rheumatology Reports (2013) Vol. 16, Iss. 2
Open Access | Times Cited: 271

Showing 76-100 of 271 citing articles:

MicroRNA and long noncoding RNA involvement in gout and prospects for treatment
Yiting Xu, Yingrong Leng, Mingming Liu, et al.
International Immunopharmacology (2020) Vol. 87, pp. 106842-106842
Closed Access | Times Cited: 24

Lower Temperatures Exacerbate NLRP3 Inflammasome Activation by Promoting Monosodium Urate Crystallization, Causing Gout
Huijeong Ahn, Gilyoung Lee, Geun‐Shik Lee
Cells (2021) Vol. 10, Iss. 8, pp. 1919-1919
Open Access | Times Cited: 23

Sensing soluble uric acid by Naip1-Nlrp3 platform
Tárcio Teodoro Braga, Mariana Rodrigues Davanso, Davi Mendes, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 22

Screening of Fv Antibodies with Specific Binding Activities to Monosodium Urate and Calcium Pyrophosphate Dihydrate Crystals for the Diagnosis of Gout and Pseudogout
Jaeyong Jung, Ji-Hong Bong, Soo‐Jeong Lee, et al.
ACS Applied Bio Materials (2021) Vol. 4, Iss. 4, pp. 3388-3397
Closed Access | Times Cited: 22

Hyperuricemia enhances procoagulant activity of vascular endothelial cells through TMEM16F regulated phosphatidylserine exposure and microparticle release
Hongyin Yu, Zelong Wang, Zhanni Li, et al.
The FASEB Journal (2021) Vol. 35, Iss. 9
Closed Access | Times Cited: 22

Glucagon-Like Peptide-1 Receptor Regulates Macrophage Migration in Monosodium Urate-Induced Peritoneal Inflammation
Jun Chen, Aihua Mei, Xinxin Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14

Folic acid-modified lysozyme protected gold nanoclusters as an effective anti-inflammatory drug for rapid relief of gout flares in hyperuricemic rats
Jiachen Sun, Pengfei Zhuang, Shan Wen, et al.
Materials & Design (2022) Vol. 217, pp. 110642-110642
Open Access | Times Cited: 14

The management of hyperuricemia: back to the pathophysiology of uric acid
Claudio Borghi
Current Medical Research and Opinion (2017) Vol. 33, Iss. sup3, pp. 1-4
Open Access | Times Cited: 27

Dual-Energy Computed Tomography
Patrick D. McLaughlin, Paul I. Mallinson, Pedro Lourenço, et al.
Radiologic Clinics of North America (2015) Vol. 53, Iss. 4, pp. 619-638
Closed Access | Times Cited: 25

Crystals and Crystal Growth
Alfred Y. Lee, Deniz Erdemir, Allan S. Myerson
Cambridge University Press eBooks (2019), pp. 32-75
Closed Access | Times Cited: 24

Consensus on patients with hyperuricemia and high cardiovascular risk treatment
И Е Чазова, Yu. V. Zhernakova, O. A. Kisliak, et al.
Systemic Hypertension (2019) Vol. 16, Iss. 4, pp. 8-21
Open Access | Times Cited: 24

The association between asymptomatic hyperuricemia and knee osteoarthritis: data from the third National Health and Nutrition Examination Survey
Shudan Wang, Michael H. Pillinger, Svetlana Krasnokutsky, et al.
Osteoarthritis and Cartilage (2019) Vol. 27, Iss. 9, pp. 1301-1308
Open Access | Times Cited: 23

An updated review for hyperuricemia and gout management; special focus on the available drug delivery systems and clinical trials
Ioannis D. Karantas, Αndroulla N. Miliotou, Panoraia I. Siafaka
Current Medicinal Chemistry (2023) Vol. 31, Iss. 36, pp. 5856-5883
Closed Access | Times Cited: 7

Obstructive Sleep Apnea: A Contributing Factor in Gout
Pushti Khandwala, Devashish Desai, Mitali Sen
Cureus (2024)
Open Access | Times Cited: 2

Changes in Serum Urate Levels after Bariatric Surgery in Patients with Obesity: An Observational Study
Daniel W. Mills, Dylan M Woolley, Basil J. Ammori, et al.
Obesity Surgery (2024) Vol. 34, Iss. 5, pp. 1737-1741
Open Access | Times Cited: 2

A machine learning-based prediction model for gout in hyperuricemics: a nationwide cohort study
Shay Brikman, Liel Serfaty, Ran Abuhasira, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 9, pp. 2411-2417
Closed Access | Times Cited: 2

TWO STILL UNANSWERED QUESTIONS ABOUT URIC ACID AND CARDIOVASCULAR PREVENTION: IS A SPECIFIC URIC ACID CUT-OFF NEEDED? IS HYPOURICEMIC TREATMENT ABLE TO REDUCE CARDIOVASCULAR RISK?
Alessandro Maloberti, Valentina Colombo, Francesca Daus, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024), pp. 103792-103792
Open Access | Times Cited: 2

Joint nociceptor nerve activity and pain in an animal model of acute gout and its modulation by intra-articular hyaluronan
Aida Marcotti, Ana Miralles-Marco, Eduardo Dominguez, et al.
Pain (2018) Vol. 159, Iss. 4, pp. 739-748
Open Access | Times Cited: 21

Disease‐Triggered Drug Release Effectively Prevents Acute Inflammatory Flare‐Ups, Achieving Reduced Dosing
Alexandra Stubelius, Wangzhong Sheng, Sang Eun Lee, et al.
Small (2018) Vol. 14, Iss. 32
Open Access | Times Cited: 21

Nanostructured TiO2 Materials for Analysis of Gout-Related Crystals Using Laser Desorption/Ionization Time-of-Flight (LDI-ToF) Mass Spectrometry
Moon-Ju Kim, Tae Gyeong Yun, Jaeyong Jung, et al.
Analytical Chemistry (2019) Vol. 91, Iss. 17, pp. 11283-11290
Closed Access | Times Cited: 20

C-reactive protein (CRP) recognizes uric acid crystals and recruits proteases C1 and MASP1
Anika Alberts, Annika Klingberg, Anne Kathrin Wessig, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 20

Neutrophils as Main Players of Immune Response towards Nondegradable Nanoparticles
Rostyslav Bilyy, Galyna Bila, О. І. Віщур, et al.
Nanomaterials (2020) Vol. 10, Iss. 7, pp. 1273-1273
Open Access | Times Cited: 19

CD40/CD40L Signaling as a Promising Therapeutic Target for the Treatment of Renal Disease
Shungang Zhang, Joshua D. Breidenbach, Benjamin Russell, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3653-3653
Open Access | Times Cited: 19

Scroll to top